Cell therapy makes progress in allergic conjunctivitis

Cell therapy makes progress in allergic conjunctivitis

Subconjunctival injection of stem cells reduces symptoms and modulates immune cell trafficking and differentiation in disease models. + read more

They establish a method for large-scale production of cytotoxic T lymphocytes

This advance could make immunotherapy safer, more effective, and less expensive across multiple indications. + read more

New CAR-T lymphocytes drive progress in cell therapy for solid tumors

New genetic modifications and selection of optimal chimeric receptors will allow long-term treatment. + read more

Up to 40% of the population suffers from eye allergies

The 20th Annual Congress of the Spanish Society of Ocular Surface and Cornea (SESOC) highlights the most significant development of allergic conjunctivitis, a disease whose prevalence is increasing, affecting both children and adults and causing a significant deterioration in their quality of life . Sometimes, irreversible vision damage occurs. + read more

Pharmacological intervention may improve bone marrow transplant outcomes

Histone deacetylase inhibitors correct epigenetic imbalances in T lymphocytes following blood regeneration. + read more

Bacterial toxins provide protection in chronic allergic asthma model

It reduces airway inflammation and cellular changes characteristic of the disease through multiple immune mechanisms. + read more